Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 24 Late-Breaking Discussion: REALIZE-K
Author(s): Harriette Van Spall , Mikhail Kosiborod Added: 1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Job title: Cardiologist
Dr Michel Komajda is a Cardiologist at theNational Academy of Medicine in Paris, France.He is a past president of the European Society of Cardiology and the French Cardiac Society.He has been a member of the steering comittee, clinical endpoint committee or DSMB of many notable heart failure clinical trials, including SHIFT, CORONA, I PRESERVE, COMET, PARADIGM HF, CARMEN, EMPHESUS, RENAISSANCE,… View more
Novi Yanti Sari
Job title: Heart Failure Cardiologist
Dr Novi Yanti Sari is a heart failure cardiologist from Indonesia. She graduated from the National Cardiovascular Center Harapan Kita–Faculty of Medicine, University of Indonesia, then pursued a fellowship in advanced HF at the National University Heart Centre Singapore. She pioneered the first heart failure and cardio-oncology pr gram in South Sumatra, Indonesia, and now leads both programs at… View more
Research Area(s) / Expertise: Job title: PhD, RD, FHFSA, FASPEN
Dr Salvatore Carbone, PhD, RDN, MS, FHFSA, FASPEN is an Associate Professor and Program Director of the Nutrition Program at the EVMS School of Health Professions, and an Associate Professor within the EVMS Division of Endocrine and Metabolic Disorders, Strelitz Diabetes Center, Department of Internal Medicine, at the Macon & Joan Brock Virginia Health Sciences at Old Dominion University… View more
3 Trials That Will Change My Practice
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC 2024 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE-HF2Recorded on-site at ESC Congress 2024, London.Editors: Jordan Rance and Mirjam Boros… View more

Heart Failure
ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D
Author(s): Steven E Nissen Added: 2 weeks ago
American College of Cardiology Congress 2026 – Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the effects of tirzepatide compared with dulaglutide on expanded cardiorenal outcomes from the SURPASS-CVOT trial (NCT04255433; Eli Lilly and Company).This international, double-blind, randomised, phase III cardiovascular outcomes trial enrolled 13,299 patients aged 40 and… View more

Cardiovascular Kidney Metabolic

Heart Failure
Job title: Senior Director of the cardiac care unit
ProfDiana Bonderman isSenior Director of the cardiac care unit at theMedical University of Vienna. Her clinical interests are Cardiovascular Medicine, Intensive care Medicine, Cardiovascular Medicine, Hemodynamics, Pulmonary Hypertension and Ejection Fraction. View more
e-SPACE CRM 2026
Author(s): Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira Start date: Apr 11, 2026

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
e-SPACE CRM 2026
Author(s): Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira Start date: Apr 10, 2026

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic